Journal of Cystic Fibrosis
Volume 4, Issue 3 , Page 209 , September 2005

Measurement of tobramycin and gentamicin in saliva is not suitable for therapeutic drug monitoring of patients with cystic fibrosis

References 

  1. Madsen V, Lind A, Rasmussen M, Coulthard K. Determination of tobramycin in saliva is not suitable for therapeutic drug monitoring of patients with cystic fibrosis. J Cyst Fibros. 2004;3:249–251
  2. Berkovitch M, Bistritzer T, Aladjem M, Burtin P, Dagan T, Chen-Levi Z, et al. Clinical relevance of therapeutic drug monitoring of digoxin and gentamicin in the saliva of children. Ther Drug Monit. 1998;20:253–256
  3. Berkovitch M, Goldman M, Silverman R, Chen-Levi Z, Greenberg R, Marcus O, et al. Therapeutic drug monitoring of once daily gentamicin in serum and saliva of children. Eur J Pediatr. 2000;159:697–698

PII: S1569-1993(05)00074-3

doi: 10.1016/j.jcf.2005.05.016

Journal of Cystic Fibrosis
Volume 4, Issue 3 , Page 209 , September 2005

Article Tools